Article

An Evidenced-Based Prior for Estimating the Treatment Effect of Phase III Randomized Trials in Oncology

2024-04-01

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Purpose</h4> The primary results of phase III oncology trials may be challenging to interpret, given that such results are generally based on meeting P -value thresholds. The probability of whether a treatment is beneficial, although a more intuitive summary of the results, is not provided by most trials. In this study, we developed and released a user-friendly tool that calculates the pro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: cc94757b-c28d-5a53-9f0c-e73f83469f17
DOI: 10.1101/2024.04.01.24305158

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

An Evidenced-Based Prior for Estimating the Treatment Effect of Phase III Randomized Trials in OncologyDOI 10.1101/2024.04.01.24305158Read

The Call for Progress in Evidence-Based MedicineSemantic proximity Read

Construction and evaluation of clinical prediction model for immunotherapy-related adverse events and clinical benefit in cancer patients receiving immune checkpoint inhibitors based on serum cytokine levelsSemantic proximity Read

The Current Landscape of Clinical TrialsSemantic proximity Read

Predicting Individual Responses in Phase I Oncology Trials Using Routinely Collected Clinical BiomarkersSemantic proximity Read

Summary measures in non-inferiority clinical trials with a time-to-event outcome: an empirical comparison of powerSemantic proximity Read

Review of calculation of conditional power, predictive power and probability of success in clinical trials with continuous, binary and time-to-event endpointsSemantic proximity Read

Favoring the hierarchical constraint in penalized survival models for randomized trials in precision medicineSemantic proximity Read

Predicting Success of Phase III Trials in OncologySemantic proximity Read

Examining the Feasibility and Functionality of Common Analysis Methods for Longitudinal Data with Binary OutcomesSemantic proximity Read

Using Median Survival in Meta-analysis of Experimental Time-to-event DataSemantic proximity Read

Exploratory Bayesian Synthesis of Targeted Agents Combined With Immune Checkpoint Inhibitors in Advanced Non–Small Cell Lung Cancer: A Network Meta-analysis of Single-Arm StudiesSemantic proximity Read

Efficacy and Safety of Post-CDK4/6 Inhibitor Treatment Options for HR-Positive, HER2-Negative Advanced Breast Cancer: A Network Meta-Analysis of Randomized Controlled TrialsSemantic proximity Read